Investment Stage

Focus Areas

About Investor

Jonathan Soll is a Senior Associate at New Rhein Healthcare Investors based in Philadelphia, specializing in life sciences investments with a focus on Medical Devices, Pharmaceuticals, Consumer Health, BioTech, Diagnostics, Drug Delivery, Therapeutics, and Digital Health, typically at Seed and Series A stages with investment ranges between $20.0M and $50.0M. He joined New Rhein in May 2022 after working as an analyst at Denovo Capital Group, an event-driven investment fund, where he developed a successful investment strategy targeting special situations within the healthcare sector. Jonathan began his career in data analytics at Quicken Loans, where he collaborated with various company areas to drive data-driven decisions, honing his analytical and strategic skills.